Dr. Mostaghel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-288-1000Fax+1 206-288-1025
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 2003 - 2006
University of California (San Francisco)Residency, Internal Medicine, 2000 - 2003
Duke University School of MedicineClass of 2000
Certifications & Licensure
CA State Medical License 2002 - Present
WA State Medical License 2003 - 2025
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers Start of enrollment: 2021 Aug 31
Roles: Contact
Publications & Presentations
PubMed
- 809 citationsIntegrative clinical genomics of advanced prostate cancer.Dan Robinson, Eliezer M Van Allen, Yi-Mi Wu, Nikolaus Schultz, Robert J Lonigro
Cell. 2015-05-21 - 202 citationsMolecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancerMark P. Labrecque, Ilsa Coleman, Lisha G. Brown, Lawrence D. True, Lori Kollath
The Journal of Clinical Investigation. 2019-10-01 - 456 citationsAndrogen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF SignalingEric G. Bluemn, Ilsa Coleman, Jared M. Lucas, Roger Coleman, Susana Hernandez-Lopez
Cancer Cell. 2017-10-09
Journal Articles
- Neoadjuvant-Intensive Androgen Deprivation Therapy Selects for Prostate Tumor Foci with Diverse Subclonal Oncogenic AlterationsElahe Mostaghel, MD, Clinical Cancer Research
- Contribution of Adrenal Glands to Intra-Tumor Androgens and Growth of Castration Resistant Prostate CancerAlvin M Matsumoto, Maria S Tretiakova, Lawrence True, Elahe A Mostaghel, Clinical Cancer Research
- Downregulation of Dipeptidyl Peptidase 4 Accelerates Progression to Castration-Resistant Prostate CancerElahe Mostaghel, MD, Clinical Cancer Research
Press Mentions
Oral Relugolix Works to a T Against Advanced Prostate CancerMay 30th, 2020
Context Partners with Research Institutions to Study Sigma1 Protein in Treatment of Fibrosis, CancerAugust 21st, 2017
Grant Support
- In Vivo Efficacy Of Multi-Targeted Androgen Inhibition As Prostate Cancer TherapyNational Cancer Institute2006–2010
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
